Literature DB >> 10971399

Kell is not restricted to the erythropoietic lineage but is also expressed on myeloid progenitor cells.

T Wagner1, A Berer, G Lanzer, K Geissler.   

Abstract

Anti-Kell antibodies have been shown to suppress fetal erythropoiesis, but little is known about their effect on myelopoiesis. We analysed the effect of Kell-related antibodies on granulocyte-macrophage colony-forming units (CFU-GM) growth in semisolid medium using peripheral blood mononuclear cells (PBMNCs) from haematologically normal individuals. In addition to its inhibitory effect on erythroid burst-forming units (BFU-E) growth, anti-Kell antibodies significantly reduced CFU-GM colony formation from Kell-positive individuals but not from Kell-negative donors. Moreover, anti-cellano and anti-Kpb antibodies also inhibited the growth of CFU-GM from antigen-positive MNCs. These data indicate that Kell is not restricted to erythroid blood cells, but is also expressed on myeloid progenitor cells.

Mesh:

Substances:

Year:  2000        PMID: 10971399     DOI: 10.1046/j.1365-2141.2000.02195.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Molecular Basis of KELnull Phenotype in Brazilians.

Authors:  Edmir Boturão-Neto; Mihoko Yamamoto; Akemi Kuroda Chiba; Elisa Yuriko Sugano Kimura; Maria do Carmo Valgueiro Costa de Oliveira; Cláudia Lumack do Monte Barretto; Mércia Maria Alves Nunes; Sérgio Roberto Lopes Albuquerque; Marcos Daniel de Deus Santos; José Orlando Bordin
Journal:  Transfus Med Hemother       Date:  2014-12-19       Impact factor: 3.747

2.  Transcriptional regulation of the KEL gene and Kell protein expression in erythroid and non-erythroid cells.

Authors:  V Camara-Clayette; C Rahuel; C Lopez; C Hattab; V Verkarre; O Bertrand; J P Cartron
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

3.  Does aberrant membrane transport contribute to poor outcome in adult acute myeloid leukemia?

Authors:  Alexandre Chigaev
Journal:  Front Pharmacol       Date:  2015-07-02       Impact factor: 5.810

4.  Successful hematopoietic stem-cell transplantation in a patient with chronic granulomatous disease and McLeod phenotype sensitized to Kx and K antigens.

Authors:  M Hönig; W A Flegel; K Schwarz; J F Freihorst; U Baumann; A Seltsam; K-M Debatin; A S Schulz; W Friedrich
Journal:  Bone Marrow Transplant       Date:  2009-06-08       Impact factor: 5.483

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.